عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
1849734143
(Number (ISBN
9781849734141
NATIONAL BIBLIOGRAPHY NUMBER
Number
b432821
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
New therapeutic strategies for type 2 diabetes :
General Material Designation
[Book]
Other Title Information
small molecule approaches /
First Statement of Responsibility
edited by Robert M. Jones
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Cambridge :
Name of Publisher, Distributor, etc.
Royal Society of Chemistry,
Date of Publication, Distribution, etc.
c2012
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xv, 515 p. :
Other Physical Details
ill. (some col.) ;
Dimensions
24 cm
SERIES
Series Title
RSC drug discovery series ;
Volume Designation
27
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Type 2 diabetes: disease overview / Daniel M. Kemp -- Marketed small molecule dipeptidyl peptidase IV (DPP4) inhibitors as a new class of oral anti-diabetics / Zhonghua Pei -- SGLT2 inhibitors in development / William N. Washburn -- Glucokinase activators in development / Kevin J. Filipski, Benjamin D. Stevens and Jeffrey A. Pfefferkorn -- 11[beta]-hydroxysteroid dehydrogenase type 1 (11[beta]-HSD1) inhibitors in development / James S. Scott and Jasen Chooramun -- Recent advances in PTP1B inhibitor development for the treatment of type 2 diabetes and obesity / Rongjun He, Li-Fan Zeng, Yantao He and Zhong-Yin Zhang -- Recent advances in the discovery of GPR119 agonists / Unmesh Shah, Scott Edmondson and Jason W. Szewczyk -- Acyl-CoA: diacylglycerol acyltransferase-1 inhibition as an approach to the treatment of type 2 diabetes / Robert L. Dow -- Stearoyl-CoA desaturase 1 (SCD1) inhibitors: bench to bedside must only go through liver / Gang Liu -- TGR5 agonists in development / Antonio Macchiarulo, Antimo Gioiello and Roberto Pellicciari -- The discovery and development of MB07803, a second generation fructose-1,6-bisphosphatase inhibitor with improved pharmacokinetic properties, as a potential treatment of type 2 diabetes / Qun Dang, Paul D. van Poelje and Mark D. Erion -- Inhibition of glycogen phosphorylase as a strategy for the treatment of type 2 diabetes / Brad R. Henke -- SIRT1 activators in development / Robert B. Perni ... [et al.] -- Long-chain free fatty acid receptor agonists / Jonathan B. Houze -- Glucagon receptor antagonists in development / Duane E. DeMong and M. W. Miller -- ACC inhibitors in development / Matthew P. Bourbeau
0
TOPICAL NAME USED AS SUBJECT
Diabetes-- Treatment
Diabetes Mellitus, Type 2-- drug therapy
Drug Discovery
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Jones, Robert M
CORPORATE BODY NAME - ALTERNATIVE RESPONSIBILITY
Royal Society of Chemistry (Great Britain)
ORIGINATING SOURCE
Date of Transaction
20130117020642.0
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
